ARTICLE | Clinical News
Macugen pegaptanib: Interim Phase II data
June 5, 2006 7:00 AM UTC
Interim data from the double-blind, dose-ranging, placebo-controlled, U.S. and European Phase II trial in 98 patients showed that intravitreal injections of Macugen met the primary endpoint of improve...